FOLH1 and neoplasm: Gafita et al. previously developed a nomogram to predict outcomes after LuPSMA that combines different clinical and imaging-related parameters including tumor PSMA-SUVmean on [68 Ga]Ga-PSMA-11 PET/CT [4].